Brief: Athenex Inc MHRA Denies Oral Paclitaxel For Metastatic Breast Cancer

Athenex

03/01/2023 13:40

Jan 3 (Reuters) - Athenex Inc  ATNX.O :
    * ATHENEX INC: MHRA DENIES ORAL PACLITAXEL FOR METASTATIC
BREAST
CANCER BASED SOLELY ON CHEMISTRY, MANUFACTURING AND CONTROL
(CMC) ISSUES
    * ATHENEX INC: ATHENEX PLANS TO REQUEST A REVIEW OF MHRA
DECISION
BY AN INDEPENDENT PANEL
    * ATHENEX INC: MHRA APPLICATION WAS SUPPLEMENTED WITH SAFETY
DATA
FROM ISPY 2 STUDY AND NO MAJOR CLINICAL EFFICACY OR SAFETY
CONCERNS WERE EXPRESSED

Source text for Eikon:  ID:nGNX1GjJgn 
Further company coverage:  ATNX.O 
 ((Reuters.Briefs@thomsonreuters.com;))